Oramed to Present at Cardiometabolic Health Congress
NEW YORK, Oct. 23, 2018 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that a scientific abstract summarizing two recent Phase IIb studies of its orally ingestible insulin capsule, ORMD-0801 in type 1 and type 2 diabetes patients will […]